Category: Dr. Joseph Skitzki


Benefit From CS/HIPEC in Advanced Abdominal Cancers

Laurie Barclay, MD Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS/HIPEC) appears to be safe and effective for select patients with advanced abdominal cancers, according to a retrospective analysis published in the June issue of Cancer Medicine. “There has been much discussion as to whether there is a benefit with this procedure, and historically it has...